Company

Mineralys Therapeutics

As of the edition of 20 October 2026, Mineralys Therapeutics runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Heart and blood vessels: 5 trials led
  • Lungs and airways: 1 trials led
  • Nervous system: 1 trials led